Tasuku Kitada

Tasuku Kitada

Company: Strand Therapeutics Inc.

Job title: President, Director, Co-founder, Head of Research & Development


Programming mRNA for Cancer Immunotherapy 10:00 am

Outlining current preclinical and clinical data indicating efficacy of mRNA cancer treatments Discussing why Strand’s approach may be superior to current mRNA drugs in the clinic The future of mRNA oncology therapy may involve precise programming of protein expression using synthetic biologyRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.